Understanding the tumor microenvironment (TME) is key to advancing cancer research and developing better therapies. Traditional tumor models often fall short, as they can’t fully capture the complex, multicellular interactions that drive tumor growth and treatment response.
This video introduces an innovative strategy: co‑culturing patient‑derived tumoroids with cancer‑associated fibroblasts (CAFs) and immune cells. By rebuilding the TME in vitro, researchers can create a more realistic “patient in a dish” model that improves drug testing and personalized oncology.